Literature DB >> 23039948

Epidermal-type FABP is a predictive marker of clinical response to systemic treatment and ultraviolet therapy in psoriatic skin lesions.

Tomomi Miyake, Eisaku Ogawa, Asuka Mikoshiba, Aya Kobayashi, Hiroaki Hosoe, Shoji Kashiwabara, Hisashi Uhara, Yuji Owada, Ryuhei Okuyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23039948     DOI: 10.1016/j.jdermsci.2012.09.002

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  5 in total

1.  Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis.

Authors:  Agnieszka Owczarczyk-Saczonek; Joanna Czerwiñska; Małgorzata Orylska; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2020-07-16       Impact factor: 1.837

2.  Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.

Authors:  Catherine A Powell; Mohd W Nasser; Helong Zhao; Jacob C Wochna; Xiaoli Zhang; Charles Shapiro; Konstantin Shilo; Ramesh K Ganju
Journal:  Oncotarget       Date:  2015-03-20

3.  Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.

Authors:  A Baran; M Świderska; Joanna Bacharewicz-Szczerbicka; H Myśliwiec; I Flisiak
Journal:  Lipids       Date:  2016-11-18       Impact factor: 1.880

4.  Clinical significance of elevated serum A-FABP and free fatty acid in neonates with hypoxic ischemic brain damage.

Authors:  Mei Li; Lian Jiang; Huifen Zhang; Dandan Wang; Min Zhang; Lianshan Zhang
Journal:  Exp Ther Med       Date:  2016-06-01       Impact factor: 2.447

5.  Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis.

Authors:  Dorota Kozłowska; Hanna Myśliwiec; Ewa Harasim-Symbor; Anna Justyna Milewska; Adrian Chabowski; Iwona Flisiak
Journal:  Mol Biol Rep       Date:  2021-06-15       Impact factor: 2.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.